About Us
Vygoris Ltd is a subsidiary of Substipharm, a privately owned French specialist generics company.
In 2017 we have acquired a product mainly used in secondary care (urology, Mitocin®) for use primarily in bladder cancer.
In 2018, we have acquired a second product mainly used in primary care (anti-fungal antibiotics, Nystan®)
Our aim is to introduce innovative and difficult to manufacture specialist products, in a range of therapy areas.